# ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"

> **NCT00180518** · PHASE2,PHASE3 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 581 (—)

## Conditions studied

- Carotid Atherosclerosis
- Carotid Artery Disease

## Interventions

- **DEVICE:** Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system

## Key facts

- **NCT ID:** NCT00180518
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2003-10
- **Final completion:** 2003-11
- **Target enrollment:** 581 (—)
- **Last updated:** 2008-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180518, "ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00180518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*